Romeo Power (RMO) 10-Q 9 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 30, 2020
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2020
Entity File Number	001-38795
Entity Registrant Name	RMG Acquisition Corp.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-2289787
Entity Address, Address Line One	50 West Street, Suite 40-C
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10006
City Area Code	212
Local Phone Number	220-9503
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Shell Company	true
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001757932
Amendment Flag	false
One Class A common stock
Title of 12(b) Security	Units, each consisting of one Class A common stock, $0.0001 par value, and one-third of one warrant to purchase one Class A common stock
Trading Symbol	RMG
Security Exchange Name	NYSE
Class A Common stock
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	RMG.UN
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		23,000,000
Class B common stock
Entity Common Stock, Shares Outstanding		5,750,000
Warrants to purchase Class A common stock
Title of 12(b) Security	Warrants to purchase Class A common stock
Trading Symbol	RMG.WT
Security Exchange Name	NYSE

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash	$ 315,502	$ 1,175,207
Prepaid expenses and other assets	144,188	176,403
Total current assets	459,690	1,351,610
Restricted cash equivalents held in Trust Account	234,179,516	233,232,730
Total Assets	234,639,206	234,584,340
Current liabilities:
Accounts payable	6,490	133,562
Accrued expenses	202,344	50,000
Franchise tax payable	150,050	200,000
Income tax payable		88,057
Total current liabilities	358,884	471,619
Deferred legal fees	450,000	450,000
Deferred underwriting commissions	8,050,000	8,050,000
Note payable	41,666
Total liabilities	8,900,550	8,971,619
Commitments and contingencies
Stockholders' Equity:
Preferred stock, $0.0001 par value 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	7,326,942	4,749,168
Retained earnings (Accumulated deficit)	(2,327,604)	250,164
Total stockholders' equity	5,000,006	5,000,001
Total Liabilities, Redeemable Class A Common Stock and Stockholders' Equity	234,639,206	234,584,340
Class A Common stock
Current liabilities:
Class A common stock, $0.0001 par value; 22,073,865 and 22,061,272 shares subject to possible redemption at $10 per share at September 30, 2020 and December 31, 2019 respectively	220,738,650	220,612,720
Stockholders' Equity:
Common stock, value	93	94
Total stockholders' equity	93	94
Class B common stock
Stockholders' Equity:
Common stock, value	575	575
Total stockholders' equity	$ 575	$ 575

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parentheticals) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common stock
Temporary equity, par value per share (in dollars per share)	$ 0.0001	$ 0.0001
Temporary equity, shares subject to possible redemption	22,073,865	22,061,272
Temporary equity, redemption price per share (in dollars per share)	$ 10	$ 10
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	926,135	938,728
Common stock shares outstanding	926,135	938,728
Number of shares issued for possible redemption	22,073,865	22,061,272
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	5,750,000	5,750,000
Common stock shares outstanding	5,750,000	5,750,000

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
General and administrative expenses	$ 589,274	$ 210,806	$ 1,049,053	$ 668,222
Franchise tax expense	50,000	50,000	150,169	150,000
Loss from operations	(639,274)	(260,806)	(1,199,222)	(818,222)
Interest income	13	8,839	1,111	22,725
Interest earned on restricted cash equivalents held in Trust Account	28,551		1,153,171
Gain on marketable securities (net), and dividends held in Trust Account		1,142,497		3,299,930
Interest expense	(104)		(104)
(Loss) income before income tax expense (benefit)	(610,814)	890,530	(45,044)	2,504,433
Income tax expense (benefit)	(119,129)	232,380	(170,979)	668,514
Net (loss) income	(491,685)	658,150	125,935	1,835,919
Class A Common stock
Net (loss) income	$ 97,680	$ 865,438	$ 1,173,981	$ 2,493,441
Weighted average shares outstanding, basic and diluted (in shares)	23,000,000	23,000,000	23,000,000	22,909,091
Basic and diluted net income (loss) per share (in dollars per share)		$ 0.04	$ 0.05	$ 0.11
Class B common stock
Net (loss) income	$ (589,365)	$ (207,288)	$ (1,048,046)	$ (657,522)
Weighted average shares outstanding, basic and diluted (in shares)	5,750,000	5,750,000	5,750,000	5,750,000
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.10)	$ (0.04)	$ (0.18)	$ (0.11)

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)	Class A Common stock	Class B common stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)	Total
Balance at Dec. 31, 2018		$ 575	$ 24,425	$ (2,555)	$ 22,445
Balance (in shares) at Dec. 31, 2018		5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Anchor Investors		$ 58	2,255		2,313
Issuance of Class B common stock to Anchor Investors (in shares)		575,000
Forfeiture of Class B common stock from Sponsor		$ (58)	58
Forfeiture of Class B common stock from Sponsor (in shares)		(575,000)
Sale of units in initial public offering, gross	$ 2,300		229,997,700		230,000,000
Sale of units in initial public offering, gross (in shares)	23,000,000
Offering costs			(13,448,120)		(13,448,120)
Sale of private placement warrants to Sponsor and Anchor Investors in private placement			6,900,000		6,900,000
Class A common stock subject to possible redemption	$ (2,188)		(218,799,442)		(218,801,630)
Class A common stock subject to possible redemption (in shares)	(21,880,163)
Class A common stock subject to possible redemption (in shares)	21,880,163
Net (loss) income				324,994	324,994
Balance at Mar. 31, 2019	$ 112	$ 575	4,676,876	322,439	5,000,002
Balance (in shares) at Mar. 31, 2019	1,119,837	5,750,000
Balance at Dec. 31, 2018		$ 575	24,425	(2,555)	22,445
Balance (in shares) at Dec. 31, 2018		5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 2,493,441	$ (657,522)			1,835,919
Balance at Sep. 30, 2019	$ 97	$ 575	4,341,185	658,150	5,000,007
Balance (in shares) at Sep. 30, 2019	968,745	5,750,000
Balance at Mar. 31, 2019	$ 112	$ 575	4,676,876	322,439	5,000,002
Balance (in shares) at Mar. 31, 2019	1,119,837	5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class A common stock subject to possible redemption	$ (9)		(530,322)	(322,439)	(852,770)
Class A common stock subject to possible redemption (in shares)	(85,277)
Class A common stock subject to possible redemption (in shares)	85,277
Net (loss) income				852,775	852,775
Balance at Jun. 30, 2019	$ 103	$ 575	4,146,554	852,775	5,000,007
Balance (in shares) at Jun. 30, 2019	1,034,560	5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class A common stock subject to possible redemption	$ (6)		194,631	(852,775)	(658,150)
Class A common stock subject to possible redemption (in shares)	(65,815)
Class A common stock subject to possible redemption (in shares)	65,815
Net (loss) income	$ 865,438	$ (207,288)		658,150	658,150
Balance at Sep. 30, 2019	$ 97	$ 575	4,341,185	658,150	5,000,007
Balance (in shares) at Sep. 30, 2019	968,745	5,750,000
Balance at Dec. 31, 2019	$ 94	$ 575	4,749,168	250,164	5,000,001
Balance (in shares) at Dec. 31, 2019	938,728	5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class A common stock subject to possible redemption	$ (6)		1,463,719	(2,086,083)	(622,370)
Class A common stock subject to possible redemption (in shares)	(62,237)
Class A common stock subject to possible redemption (in shares)	62,237
Net (loss) income				622,375	622,375
Balance at Mar. 31, 2020	$ 88	$ 575	6,212,887	(1,213,544)	5,000,006
Balance (in shares) at Mar. 31, 2020	876,491	5,750,000
Balance at Dec. 31, 2019	$ 94	$ 575	4,749,168	250,164	5,000,001
Balance (in shares) at Dec. 31, 2019	938,728	5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of units in initial public offering, gross					230,000,000
Net (loss) income	$ 1,173,981	$ (1,048,046)			125,935
Balance at Sep. 30, 2020	$ 93	$ 575	7,326,942	(2,327,604)	5,000,006
Balance (in shares) at Sep. 30, 2020	926,135	5,750,000
Balance at Mar. 31, 2020	$ 88	$ 575	6,212,887	(1,213,544)	5,000,006
Balance (in shares) at Mar. 31, 2020	876,491	5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class A common stock subject to possible redemption			627,125	(622,375)	4,750
Class A common stock subject to possible redemption (in shares)	(475)
Class A common stock subject to possible redemption (in shares)	475
Net (loss) income				(4,755)	(4,755)
Balance at Jun. 30, 2020	$ 88	$ 575	6,840,012	(1,840,674)	5,000,001
Balance (in shares) at Jun. 30, 2020	876,966	5,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class A common stock subject to possible redemption	$ 5		486,930	4,755	491,690
Class A common stock subject to possible redemption (in shares)	(49,169)
Class A common stock subject to possible redemption (in shares)	49,169
Net (loss) income	$ 97,680	$ (589,365)		(491,685)	(491,685)
Balance at Sep. 30, 2020	$ 93	$ 575	$ 7,326,942	$ (2,327,604)	$ 5,000,006
Balance (in shares) at Sep. 30, 2020	926,135	5,750,000

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net income	$ 125,935	$ 1,835,919
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Gain on marketable securities (net), and dividends held in Trust Account		(3,299,930)
Changes in operating assets and liabilities:
Prepaid expenses	115,187	(172,974)
Accounts payable	(127,072)	109,264
Accrued expenses	152,344	13,000
Due to related parties		(40,381)
Franchise tax payable	(49,950)	150,000
Income tax payable	(171,029)	591,258
Net cash provided by (used in) operating activities	45,415	(813,844)
Cash Flows from Investing Activities
Purchase of marketable securities held in Trust Account		(575,947,949)
Proceeds received from sales, redemptions and maturities of marketable securities held in Trust Account		346,951,000
Net cash provided by investing activities		(228,996,949)
Cash Flows from Financing Activities:
Proceeds received under loans from related parties		38,501
Repayment of amounts due to related parties		(113,501)
Proceeds from issuance of Class B common stock to anchor investors		2,313
Proceeds received from initial public offering, gross		230,000,000
Proceeds received from private placement		6,900,000
Proceeds received under PPP loan from Small Business Administration	41,666
Offering costs paid		(4,758,272)
Net cash provided by financing activities	41,666	232,069,041
Net increase in cash and cash equivalents	87,081	2,258,248
Cash - beginning of the period	234,407,937	37,044
Cash and restricted cash equivalents held in Trust Account - end of the period	234,495,018	2,295,292
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accrued expenses		100,000
Forfeiture of Class B common stock from Sponsor		58
Deferred underwriting commissions in connection with the initial public offering		8,050,000
Deferred legal fees in connection with the initial public offering		150,000
Reclassification of deferred offering costs to equity upon completion of the initial public offering		670,220
Value of common stock subject to possible redemption	$ 125,930	220,312,550
Supplemental cash flow disclosure:
Cash paid for income taxes		$ 77,257

Description of Organization, Bu

Description of Organization, Business Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2020
Description of Organization, Business Operations and Basis of Presentation
Description of Organization, Business Operations and Basis of Presentation	Note 1 — Description of Organization, Business Operations and Basis of Presentation RMG Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on October 22, 2018 (date of inception) for the purpose of effecting a merger, capital stock exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus its search for a target business in the diversified resources and industrial materials sectors. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of September 30, 2020, the Company had not commenced any operations. All activity for the period from October 22, 2018 (date of inception) through September 30, 2020 relates to the Company’s formation, the preparation for the initial public offering (“Initial Public Offering”), and since the Initial Public Offering, the search for a target for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is RMG Sponsor, LLC, a Delaware limited liability company (the “Sponsor”). The Company’s ability to commence operations is contingent upon obtaining adequate financial resources. The registration statement for the Company’s Initial Public Offering was declared effective on February 12, 2019. On February 12, 2019, the Company consummated its Initial Public Offering of 20,000,000 units (“Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”), and on February 19, 2019, the underwriters fully exercised their over-allotment option to purchase 3,000,000 additional Units to cover over-allotments at $10.00 per Unit, generating aggregate gross proceeds of $230 million, and incurring offering costs of approximately $13.4 million, inclusive of $8.05 million in deferred underwriting commissions (Note 7). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,000,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor and the Anchor Investors (as defined in Note 3), generating gross proceeds of $6.0 million (Note 4). In connection with the full exercise of the over-allotment option by the underwriters, the Sponsor and the Anchor Investors purchased an additional 600,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, which generated additional gross proceeds of $900,000. Upon the closing of the Initial Public Offering and Private Placement, $230 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in a trust account (the “Trust Account”), located at Deutsche Bank Trust Company Americas, with American Stock Transfer & Trust Company acting as trustee, and were invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Class A common stock, par value $0.0001, sold in the Initial Public Offering (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially at $10.00 per Public Share). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined below in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Sponsor has agreed to waive its redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, the Company’s amended and restated certificate of incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A common stock sold in the Initial Public Offering, without the prior consent of the Company. The Sponsor and the Company’s officers and certain directors have agreed not to propose an amendment to the Company’s amended and restated certificate of incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Class A common stock in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or February 12, 2021 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes as well as expenses relating to the administration of the Trust Account (less up to $100,000 of interest released to the Company to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and its Board, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the warrants, which will expire worthless if the Company fails to complete its Business Combination within the prescribed time period. The Sponsor, officers and certain directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor, officers or directors acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters of the Initial Public Offering have agreed to waive their rights to its deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Basis of Presentation The accompanying unaudited condensed interim financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed interim financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ended December 31, 2020, or any future period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements contained in the Company’s Annual Report on Form 10-K filed with the SEC on March 16, 2020. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has irrevocably elected to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, will adopt the new or revised standard at the time public companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another emerging growth company which has not opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Going Concern Consideration As of September 30, 2020, the Company had approximately $316,000 in its operating bank account held outside of the Trust Account, and approximately $4.2 million of investment income earned on money market funds and marketable securities held in the Trust Account available to pay franchise tax and income tax obligations. The Company will use the funds available outside of the Trust Account primarily to meet the Company's operating cash flow and working capital needs. Through September 30, 2020, the Company’s liquidity needs have been satisfied through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares (as defined in Note 6), approximately $153,000 received from the Sponsor under Expenses Reimbursement arrangement in 2019 (see Note 6), the proceeds from the consummation of the Private Placement not held in the Trust Account and the loan proceeds under the PPP Note (see Note 5) received in June 2020. The Company fully repaid the loans from the Sponsor in 2019. The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing investment income earned on the Trust Account (less amounts released to the Company for taxes payable, expenses relating to the administration of the Trust Account and deferred underwriting commissions) to complete the Initial Business Combination. On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Updated (“ASU”) 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, management has determined that the mandatory liquidation and subsequent dissolution related to the Combination Period described above raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 12, 2021.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Net Income per Common Stock Net income per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 12,266,666 Class A common stock in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted earnings per ordinary share is the same as basic earnings per ordinary share for the periods presented. The Company’s statements of operations include a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per common stock, basic and diluted for Class A common stock is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of Class A common stock outstanding for the periods. Net loss per common stock, basic and diluted for Class B common stock is calculated by dividing the net income, less income attributable to Class A common stock and any working capital loans, by the weighted average number of Class B common stock outstanding for the periods presented. The Company’s net income is adjusted for the portion of income that is attributable to Class A common stock subject to redemption, as these shares only participate in the earnings of the Trust Account (less applicable taxes) and not the income or losses of the Company. Accordingly, basic and diluted income per Class A common stock is calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ ​ September 30, 2020 ​ September 30, 2019 ​ September 30, 2020 ​ September 30, 2019 ​ Interest income on restricted cash equivalents held in Trust Account ​ $ 28,551 ​ $ 5,321 ​ $ 1,153,171 ​ $ 12,025 ​ Gain on marketable securities (net), and dividends held in Trust Account ​ — ​ 1,142,497 ​ — ​ 3,299,930 Expenses available to be paid with interest income from Trust ​ 69,129 ​ ​ (282,380) ​ 20,810 ​ ​ (818,514) ​ Net income available to holders of Class A common stock ​ 97,680 ​ ​ 865,438 ​ 1,173,981 ​ ​ 2,493,441 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net (loss) income ​ ​ (491,685) ​ ​ 658,150 ​ ​ 125,935 ​ ​ 1,835,919 ​ Less: Income attributable to Class A common stock ​ (97,680) ​ ​ (865,438) ​ (1,173,981) ​ ​ (2,493,441) ​ Net loss attributable to holders of Class B common stock ​ $ (589,365) ​ $ (207,288) ​ $ (1,048,046) ​ $ (657,522) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding of Class A common stock ​ 23,000,000 ​ ​ 23,000,000 ​ 23,000,000 ​ ​ 22,909,091 ​ Basic and diluted net income per share, Class A ​ $ - ​ $ 0.04 ​ $ 0.05 ​ $ 0.11 ​ Weighted average shares outstanding of Class B common stock ​ 5,750,000 ​ ​ 5,750,000 ​ 5,750,000 ​ ​ 5,750,000 ​ Basic and diluted net loss per share, Class B ​ $ (0.10) ​ $ (0.04) ​ $ (0.18) ​ $ (0.11) ​ ​ Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk consist principally of cash, restricted cash equivalents held in the Trust Account, and marketable securities held in the Trust Account. Cash and restricted cash equivalents are maintained in accounts with financial institutions, which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant. As of September 30, 2020 and December 31, 2019, the balance of restricted cash equivalents held in the Trust Account are comprised entirely of an investment in a single money market fund which invests all of its assets in cash, U.S. Treasury bills, notes, and other obligations issued or guaranteed as to principal and interest by the U.S. Treasury. As of September 30, 2020 and December 31, 2019, the Company had no investments in marketable securities. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had approximately $234.2 million and $233.2 million in restricted cash equivalents held in the Trust Account as of September 30, 2020 and December 31, 2019, respectively. The following table provides a reconciliation of cash and cash equivalents reported within the financial statements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2020 December 31, 2019 ​ Cash ​ $ 315,502 ​ $ 1,175,207 ​ Restricted cash equivalents held in Trust Account ​ 234,179,516 ​ 233,232,730 ​ Total cash and restricted cash equivalents held in Trust Account shown in the statement of cash flows ​ $ 234,495,018 ​ $ 234,407,937 ​ ​ Marketable Securities Held in the Trust Account At times, the Company invests in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities (net), dividends and interest, held in the Trust Account in the accompanying statements of operations. The estimated fair values of marketable securities held in the Trust Account are determined using available market information. As of September 30, 2020, and December 31, 2019, the Company had no investments in marketable securities. Fair Value of Financial Instruments Fair value measurements are based on the premise that fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the following three-tier fair value hierarchy has been used in determining the inputs used in measuring fair value (see Note 9): Level 1 – Quoted prices in active markets for identical assets or liabilities on the reporting date. Level 2 – Pricing inputs are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Pricing inputs are generally unobservable and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require management’s judgment or estimation of assumptions that market participants would use in pricing the assets or liabilities. The fair values are therefore determined using factors that involve considerable judgment and interpretations, including but not limited to private and public comparables, third-party appraisals, discounted cash flow models, and fund manager estimates. As of September 30, 2020, and December 31, 2019, the recorded values of cash and restricted cash equivalents held in the Trust Account, prepaid expenses, accounts payable, and accrued expenses approximate the fair values due to the short-term nature of the instruments. Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred of approximately $13.4 million that are directly related to the Initial Public Offering. These costs were charged to stockholders’ equity upon the completion of the Initial Public Offering in February 2019. As of December 31, 2019, the Company had $50,000 of accrued offering costs in the accompanying balance sheet. During the three months ended September 30, 2020, the Company reversed the remaining accrued offering costs against additional paid-in-capital in the accompanying balance sheet. Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Management has determined that a full valuation allowance on the deferred tax asset (related to start-up costs) is appropriate at this time after consideration of all available positive and negative evidence related to the realization of the deferred tax asset. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020 and December 31, 2019. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Class A Common Stock Subject to Possible Redemption Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2020 and December 31, 2019, 22,073,865 and 22,061,272 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets. Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2020
Initial Public Offering
Initial Public Offering	Note 3 — Initial Public Offering On February 12, 2019, the Company sold 20,000,000 Units at a purchase price of $10.00 per Unit in the Initial Public Offering. Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (“Public Warrant”). On February 19, 2019, the underwriters fully exercised their over-allotment option to purchase 3,000,000 additional Units to cover over-allotments at $10.00 per Unit, generating additional gross proceeds of $30.0 million. Each whole Public Warrant will entitle the holder to purchase one Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 8). Of the Units sold in the Initial Public Offering, an aggregate of 2,530,000 Units were purchased by certain funds and accounts managed by subsidiaries of BlackRock, Inc. and certain funds and accounts managed by Alta Fundamental Advisers LLC (together, the “Anchor Investors”).

Private Placement

Private Placement	9 Months Ended
	Sep. 30, 2020
Private Placement
Private Placement	Note 4 — Private Placement On February 12, 2019, the Company sold 4,000,000 Private Placement Warrants to the Sponsor and the Anchor Investors at $1.50 per warrant, generating gross proceeds of $6.0 million in the Private Placement. On February 19, 2019, in connection with the full exercise of the over-allotment option by the underwriters, the Sponsor and the Anchor Investors purchased 600,000 additional Private Placement Warrants, which generated additional gross proceeds of $900,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at $11.50 per share. A portion of the net proceeds from the Private Placement was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2020
Notes Payable
Notes Payable	Note 5 — Notes Payable On June 24, 2020, the Company received loan proceeds in the amount of $41,666 under the Paycheck Protection Program (“PPP Note”) from Canandaigua National Bank & Trust (“Lender”). The PPP Note was established as part of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), provides for loans to qualifying businesses for amounts up to 2.5 times the average monthly payroll expenses of the qualifying business. The PPP Note bears interest at 1.00% per annum, payable monthly beginning October 18, 2021, and is due on June 18, 2025. The PPP Note may be repaid at any time without penalty. Under the Payroll Protection Program, the Company will be eligible for loan forgiveness up to the full amount of the PPP Note and any accrued interest as the borrower uses the loan proceeds for eligible purposes, including payroll, benefits, rent, and utilities, and maintains its payroll levels. No assurance is provided that the Company will obtain forgiveness under the PPP Note in whole or in part. The PPP Note contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, or provisions of the promissory note. The occurrence of an event of default may result in a claim for the immediate repayment of all amounts outstanding under the PPP Note.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions
Related Party Transactions	Note 6 — Related Party Transactions Founder Shares On November 6, 2018, the Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock, par value $0.0001 per share (the “Class B common stock”), for an aggregate price of $25,000. On December 17, 2018, the Company effectuated an 0.8-for-1 reverse split of the Founder Shares, resulting in an aggregate outstanding amount of 5,750,000 Founder Shares. In January 2019, the Sponsor forfeited to the Company 575,000 Founder Shares and the Anchor Investors purchased from the Company 575,000 Founder Shares for cash consideration of approximately $2,300. Additionally, the Sponsor had agreed to forfeit up to 750,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. On February 19, 2019, the underwriters fully exercised its over-allotment option; thus, these shares were no longer subject to forfeiture. The Founder Shares will automatically convert into Class A common stock on a one-for-one basis at the time of the Company’s initial Business Combination and are subject to certain transfer restrictions. Related Party Reimbursements and Loans The Sponsor and the management agreed to cover for certain general and administrative expenses and offering costs in connection with the Initial Public Offering (“Expenses Reimbursement”), and expected to be reimbursed upon the completion of the Initial Public Offering. The Company borrowed approximately $153,000 under the Expenses Reimbursement and fully repaid this amount to the related parties in 2019. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds held in the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination is not completed, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. To date, except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.

Commitments & Contingencies

Commitments & Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments & Contingencies
Commitments & Contingencies	Note 7 — Commitments & Contingencies Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights (in the case of the Founder Shares, only after conversion of such shares to Class A common stock) pursuant to a registration and shareholder rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at $10.00 per Unit, less underwriting discounts and commissions. On February 19, 2019, the underwriters fully exercised its over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per unit, or $4.6 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $8.05 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred underwriting commissions will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Lease Agreement In November 2018, the Company entered into a lease agreement for its office space in New York starting in January 2019, which called for a monthly rent of $10,000 and a security deposit of $20,000. Effective December 2019, the Company entered into an annual lease agreement for its new office space. The agreement called for a security deposit of approximately $12,000 and a monthly rent of approximately $8,000. In May 2020, the Company cancelled the lease and in August 2020 received the security deposit back, net of repair costs. As of September 30, 2020, and December 31, 2019, approximately $12,000 and $32,000 related to the security deposit was recorded in Prepaid expenses and other assets, respectively. For the three months ended September 30, 2020 and 2019, the Company recorded rent expense of approximately $38,000 and $32,000 in the accompanying statements of operations, respectively. For the nine months ended September 30, 2020 and 2019, the Company recorded rent expense of approximately $61,000 and $61,000 in the accompanying statements of operations, respectively. Deferred legal fees The Company entered into an engagement letter to obtain legal advisory services, pursuant to which the legal counsel agreed to defer all fees until the closing of a Business Combination. As of September 30, 2020, and December 31, 2019, the Company recorded an aggregate of $450,000 in connection with such arrangement in deferred legal fees in the accompanying balance sheet, respectively. Litigation To our knowledge, there is no litigation currently pending or contemplated against the Company, any of its officers or directors in their capacity as such or against any of the Company’s property. From time to time, the Company could become involved in disputes and various litigation matters that arise in the normal course of business. These may include disputes and lawsuits related to intellectual property, licensing, contract law and employee relations matters. Periodically, the Company reviews the status of significant matters, if any exist, and assesses its potential financial exposure. If the potential loss from any claim or legal claim is considered probable and the amount can be estimated, the Company accrues a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability, if any, related to pending claims and litigation.

Stockholder's Equity

Stockholder's Equity	9 Months Ended
	Sep. 30, 2020
Stockholder's Equity
Stockholder's Equity	Note 8 — Stockholder’s Equity Common stock Class A Common stock Class B Common stock Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of the Class A common stock and holders of the Class B common stock will vote together as a single class on all matters submitted to a vote of the Company’s stockholders, except as required by law. The Class B common stock will automatically convert into Class A common stock at the time of the initial Business Combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like), and subject to further adjustment. Preferred Stock Warrants —  Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor and the Company’s officers and directors or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption; and ● if, and only if, the last reported last sale price of the Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. Additionally, commencing ninety days after the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants (except with respect to the Private Placement Warrants) in whole and not in part, for the number of Class A common stock determined by reference to the table set forth in the Company’s prospectus relating to the Initial Public Offering based on the redemption date and the “fair market value” of the Class A common stock, upon a minimum of 30 days’ prior written notice of redemption and if, and only if, the last sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the Public Warrant holders. The “fair market value” of the Class A common stock is the average last reported sale price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of Public Warrants. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share capitalization, or recapitalization, reorganization, merger or consolidation. If, in connection with the closing of the initial Business Combination, the Company issues additional shares of common stock or securities convertible into or exercisable or exchangeable for shares of common stock for capital raising purposes at an issue price or effective issue price of less than $9.20 per share, the warrant exercise price will be adjusted to be equal to 115% of the price received in the new issuance. The Company adopted the provisions of ASU 2017-11 effective January 1, 2019. As a result, this exercise price reset provision was excluded from the assessment of whether the warrants are considered indexed to the Company’s own stock. The warrants otherwise meet the requirements for equity classification, as such were initially classified in stockholder’s equity. The Company will recognize the value of the exercise price reset provision if and when it becomes triggered, by recognizing the value of the effect of the exercise price reset as a deemed dividend and a reduction of income available to common shareholders in computing basic earnings per share. Additionally, in no event will the Company be required to net cash settle the warrants shares. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2020
Fair Value Measurements
Fair Value Measurements	Note 9 — Fair Value Measurements The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2020 and December 31, 2019 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2020 ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Active ​ Significant Other ​ Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets held in Trust: ​ ​ ​ ​ ​ U.S. Treasury Securities ​ $ — ​ $ — ​ $ — Cash equivalents - money market funds ​ 234,179,516 ​ — ​ — ​ ​ $ 234,179,516 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2019 ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Active ​ Significant Other ​ Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets held in Trust: ​ ​ ​ ​ ​ U.S. Treasury Securities ​ $ — ​ $ — ​ $ — Cash equivalents - money market funds ​ 233,232,730 ​ — ​ — ​ ​ $ 233,232,730 ​ $ — ​ $ — ​ Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers levels Level 1 instruments include investments in money market funds and U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. ​ Proposed Business Combination ​ On October 5, 2020, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, RMG Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (“Merger Sub”), and Romeo Systems, Inc., a Delaware corporation (“Romeo”), which provides for, among other things the merger of Merger Sub with and into Romeo, with Romeo continuing as the surviving corporation (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Transactions”). As a result of the Transactions, Romeo will become a wholly-owned subsidiary of the Company, with the stockholders of Romeo becoming stockholders of the Company ​ Under the Merger Agreement, the stockholders of Romeo will receive a number of shares of the Company’s common stock based on an exchange ratio (the “Exchange Ratio”), the numerator of which is equal to $900 million (plus net cash of Romeo less debt of Romeo, plus the aggregate exercise price of all Romeo options and warrants (all calculated at the closing of the Merger)) divided by $10.00 , and the denominator of which is equal to the number of outstanding shares of Romeo, including shares issuable upon conversion of outstanding convertible notes. The holders of Romeo options and warrants will receive the Company’s options and warrants equal to the number of shares of Romeo Common Stock subject to the Romeo options and warrants multiplied by the Exchange Ratio at an exercise price per share divided by the Exchange Ratio ​ In connection with the Transactions, the Sponsor, agreed to enter into a lock-up agreement, pursuant to which the Company’s common stock received upon conversion of the shares of the Company’s Class B common stock held by the Sponsor will be subject to transfer restrictions until the earlier of (i) one year from the closing of the Merger, (ii) the date on which the last sales price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30 -trading day period commencing 150 trading days after the closing of the Merger and (iii) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property, and the warrants held by the Sponsor will be subject to transfer restrictions until the date that is 30 days following the closing of the Merger. ​ Certain stockholders of Romeo receiving shares of the Company’s common stock in connection with the Merger will be subject to a 180 -day lockup period for all shares of the Company’s common stock held by such persons. ​ The Merger Agreement contains certain representations and warranties of the parties to the Merger Agreement and consummation of the Transactions is conditioned on approval thereof by the Company’s stockholders and is further conditioned upon, representations and warranties of the parties and other closing conditions. ​ The Merger Agreement may be terminated at any time, but not later than the closing of the Merger, as follows: ● by mutual written consent of the Company and Romeo; ● by either the Company or Romeo if the Transactions are not consummated on or before the later of February 12, 2021 and such later date as the Company’s stockholders may approve, provided that the terminating party shall not have been the primary cause of the failure to close by such date; ● by either the Company or Romeo if consummation of the Transactions is permanently enjoined or prohibited by the terms of a final, non-appealable order, decree or ruling of a governmental entity or a statute, rule or regulation, provided that the terminating party shall not have been the primary cause of thereof; ● by either the Company or Romeo if the other party has breached any of its representations, warranties or covenants, such that the closing conditions would not be satisfied at the closing, and has not cured such breach within 45 days of notice from the other party of its intent to terminate, provided that the terminating party is itself not in breach; ● by the Company if Romeo stockholder approval of the Transactions has not been obtained within three business days following the date that the Registration Statement is disseminated by Romeo to its stockholders; or ● by either the Company or Romeo if, at the Company’s shareholder meeting, the Transactions shall fail to be approved by the required vote described herein (subject to any adjournment or recess of the meeting). ​ At the closing of the Merger, certain of Romeo’s stockholders and other parties thereto will enter into an Amended and Restated Registration Rights Agreement (the “Registration Rights Agreement”) pursuant to which the Company agreed to file a shelf registration statement with respect to the registrable securities under the Registration Rights Agreement. The Company also agreed to provide customary “piggyback” registration rights. The Registration Rights Agreement also provides that the Company will pay certain expenses relating to such registrations and indemnify the stockholders against certain liabilities. ​ At the closing of the Merger, the Sponsor and certain stockholders of Romeo will enter into a Stockholders’ Agreement (the “Stockholders’ Agreement”) with the Company, pursuant to which the stockholders of Romeo will have the right to designate up to two directors for election to the Company’s board of directors (of which BorgWarner, Inc. has the right to select one director provided that it maintains ownership of a certain percentage interest in the Company) for so long as they maintain collective ownership of a certain percentage interest in the Company and the Sponsor will have the right to designate up to two directors for election to the Company’s board of directors for so long as it maintains ownership of a certain percentage interest in the Company. ​ In connection with the execution of the Merger Agreement, certain stockholders of Romeo who hold a majority of the outstanding stock of Romeo have entered into support agreements pursuant to which they will agree to vote in favor of the Transactions at a meeting called to approve the Transactions by Romeo stockholders (or to act by written consent approving the Transactions). ​ In connection with the execution of the Merger Agreement, the Company entered into Subscription Agreements with certain accredited investors or qualified institutional buyers (collectively, the “Subscription Investors”) concurrently with the execution of the Merger Agreement on October 5, 2020. Pursuant to the Subscription Agreements, the Subscription Investors agreed to subscribe for and purchase, and the Company agreed to issue and sell, to the Subscription Investors an aggregate of 15,000,000 shares of Class A common stock of the Company for a purchase price of $10.00 per share, or an aggregate of approximately $150 million, in a private placement. Additionally, the Company has granted a Subscription Investor a 30-day option to purchase an additional 2,500,000 shares of Class A common stock at the same purchase price and on the same terms as described in the Subscription Agreements. The closing of the private placement will occur on the date of and immediately prior to the consummation of the Transactions and is conditioned thereon and on other customary closing conditions. The Class A common stock to be issued pursuant to the Subscription Agreements has not been registered under the Securities Act, and will be issued in reliance upon the exemption provided under Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Subscription Agreements will terminate and be void and of no further force or effect upon the earlier to occur of: (a) such date and time as the Merger Agreement is validly terminated in accordance with its terms, (b) upon the mutual written consent of each of the parties to each such Subscription Agreement, (c) the Company's notification to the Subscriber Investor in writing that it has abandoned its plans to move forward with the Transactions and/or terminates Subscriber's obligations, (d) if the conditions to closing set forth in the Subscription Agreement are not satisfied on or prior to the closing date and, as a result thereof, the transactions contemplated by the Subscription Agreement are not consummated at the closing or (e) at the election of Subscriber, on or after the date that is 270 days after the date hereof if the closing has not occurred on or prior to such date. ​ ​ ​ ​

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed interim financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, the unaudited condensed interim financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ended December 31, 2020, or any future period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements contained in the Company’s Annual Report on Form 10-K filed with the SEC on March 16, 2020.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has irrevocably elected to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, will adopt the new or revised standard at the time public companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another emerging growth company which has not opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Going Concern Consideration	Going Concern Consideration As of September 30, 2020, the Company had approximately $316,000 in its operating bank account held outside of the Trust Account, and approximately $4.2 million of investment income earned on money market funds and marketable securities held in the Trust Account available to pay franchise tax and income tax obligations. The Company will use the funds available outside of the Trust Account primarily to meet the Company's operating cash flow and working capital needs. Through September 30, 2020, the Company’s liquidity needs have been satisfied through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares (as defined in Note 6), approximately $153,000 received from the Sponsor under Expenses Reimbursement arrangement in 2019 (see Note 6), the proceeds from the consummation of the Private Placement not held in the Trust Account and the loan proceeds under the PPP Note (see Note 5) received in June 2020. The Company fully repaid the loans from the Sponsor in 2019. The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing investment income earned on the Trust Account (less amounts released to the Company for taxes payable, expenses relating to the administration of the Trust Account and deferred underwriting commissions) to complete the Initial Business Combination. On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. The impact of the COVID-19 outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the COVID-19 outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Updated (“ASU”) 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, management has determined that the mandatory liquidation and subsequent dissolution related to the Combination Period described above raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 12, 2021.
Net Income per Common Stock	Net Income per Common Stock Net income per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placement to purchase an aggregate of 12,266,666 Class A common stock in the calculation of diluted earnings per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted earnings per ordinary share is the same as basic earnings per ordinary share for the periods presented. The Company’s statements of operations include a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per common stock, basic and diluted for Class A common stock is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of Class A common stock outstanding for the periods. Net loss per common stock, basic and diluted for Class B common stock is calculated by dividing the net income, less income attributable to Class A common stock and any working capital loans, by the weighted average number of Class B common stock outstanding for the periods presented. The Company’s net income is adjusted for the portion of income that is attributable to Class A common stock subject to redemption, as these shares only participate in the earnings of the Trust Account (less applicable taxes) and not the income or losses of the Company. Accordingly, basic and diluted income per Class A common stock is calculated as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ ​ September 30, 2020 ​ September 30, 2019 ​ September 30, 2020 ​ September 30, 2019 ​ Interest income on restricted cash equivalents held in Trust Account ​ $ 28,551 ​ $ 5,321 ​ $ 1,153,171 ​ $ 12,025 ​ Gain on marketable securities (net), and dividends held in Trust Account ​ — ​ 1,142,497 ​ — ​ 3,299,930 Expenses available to be paid with interest income from Trust ​ 69,129 ​ ​ (282,380) ​ 20,810 ​ ​ (818,514) ​ Net income available to holders of Class A common stock ​ 97,680 ​ ​ 865,438 ​ 1,173,981 ​ ​ 2,493,441 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net (loss) income ​ ​ (491,685) ​ ​ 658,150 ​ ​ 125,935 ​ ​ 1,835,919 ​ Less: Income attributable to Class A common stock ​ (97,680) ​ ​ (865,438) ​ (1,173,981) ​ ​ (2,493,441) ​ Net loss attributable to holders of Class B common stock ​ $ (589,365) ​ $ (207,288) ​ $ (1,048,046) ​ $ (657,522) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding of Class A common stock ​ 23,000,000 ​ ​ 23,000,000 ​ 23,000,000 ​ ​ 22,909,091 ​ Basic and diluted net income per share, Class A ​ $ - ​ $ 0.04 ​ $ 0.05 ​ $ 0.11 ​ Weighted average shares outstanding of Class B common stock ​ 5,750,000 ​ ​ 5,750,000 ​ 5,750,000 ​ ​ 5,750,000 ​ Basic and diluted net loss per share, Class B ​ $ (0.10) ​ $ (0.04) ​ $ (0.18) ​ $ (0.11) ​
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to credit risk consist principally of cash, restricted cash equivalents held in the Trust Account, and marketable securities held in the Trust Account. Cash and restricted cash equivalents are maintained in accounts with financial institutions, which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant. As of September 30, 2020 and December 31, 2019, the balance of restricted cash equivalents held in the Trust Account are comprised entirely of an investment in a single money market fund which invests all of its assets in cash, U.S. Treasury bills, notes, and other obligations issued or guaranteed as to principal and interest by the U.S. Treasury. As of September 30, 2020 and December 31, 2019, the Company had no investments in marketable securities.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had approximately $234.2 million and $233.2 million in restricted cash equivalents held in the Trust Account as of September 30, 2020 and December 31, 2019, respectively. The following table provides a reconciliation of cash and cash equivalents reported within the financial statements: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2020 December 31, 2019 ​ Cash ​ $ 315,502 ​ $ 1,175,207 ​ Restricted cash equivalents held in Trust Account ​ 234,179,516 ​ 233,232,730 ​ Total cash and restricted cash equivalents held in Trust Account shown in the statement of cash flows ​ $ 234,495,018 ​ $ 234,407,937 ​ ​
Marketable Securities Held in the Trust Account	Marketable Securities Held in the Trust Account At times, the Company invests in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities (net), dividends and interest, held in the Trust Account in the accompanying statements of operations. The estimated fair values of marketable securities held in the Trust Account are determined using available market information. As of September 30, 2020, and December 31, 2019, the Company had no investments in marketable securities.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value measurements are based on the premise that fair value is an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the following three-tier fair value hierarchy has been used in determining the inputs used in measuring fair value (see Note 9): Level 1 – Quoted prices in active markets for identical assets or liabilities on the reporting date. Level 2 – Pricing inputs are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Pricing inputs are generally unobservable and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require management’s judgment or estimation of assumptions that market participants would use in pricing the assets or liabilities. The fair values are therefore determined using factors that involve considerable judgment and interpretations, including but not limited to private and public comparables, third-party appraisals, discounted cash flow models, and fund manager estimates. As of September 30, 2020, and December 31, 2019, the recorded values of cash and restricted cash equivalents held in the Trust Account, prepaid expenses, accounts payable, and accrued expenses approximate the fair values due to the short-term nature of the instruments.
Offering Costs	Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred of approximately $13.4 million that are directly related to the Initial Public Offering. These costs were charged to stockholders’ equity upon the completion of the Initial Public Offering in February 2019. As of December 31, 2019, the Company had $50,000 of accrued offering costs in the accompanying balance sheet. During the three months ended September 30, 2020, the Company reversed the remaining accrued offering costs against additional paid-in-capital in the accompanying balance sheet.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Management has determined that a full valuation allowance on the deferred tax asset (related to start-up costs) is appropriate at this time after consideration of all available positive and negative evidence related to the realization of the deferred tax asset. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2020 and December 31, 2019. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at September 30, 2020 and December 31, 2019, 22,073,865 and 22,061,272 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features, (Part II) Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies
Schedule of basic and diluted loss per common stock	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the three months ended ​ For the nine months ended ​ ​ ​ September 30, 2020 ​ September 30, 2019 ​ September 30, 2020 ​ September 30, 2019 ​ Interest income on restricted cash equivalents held in Trust Account ​ $ 28,551 ​ $ 5,321 ​ $ 1,153,171 ​ $ 12,025 ​ Gain on marketable securities (net), and dividends held in Trust Account ​ — ​ 1,142,497 ​ — ​ 3,299,930 Expenses available to be paid with interest income from Trust ​ 69,129 ​ ​ (282,380) ​ 20,810 ​ ​ (818,514) ​ Net income available to holders of Class A common stock ​ 97,680 ​ ​ 865,438 ​ 1,173,981 ​ ​ 2,493,441 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net (loss) income ​ ​ (491,685) ​ ​ 658,150 ​ ​ 125,935 ​ ​ 1,835,919 ​ Less: Income attributable to Class A common stock ​ (97,680) ​ ​ (865,438) ​ (1,173,981) ​ ​ (2,493,441) ​ Net loss attributable to holders of Class B common stock ​ $ (589,365) ​ $ (207,288) ​ $ (1,048,046) ​ $ (657,522) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted average shares outstanding of Class A common stock ​ 23,000,000 ​ ​ 23,000,000 ​ 23,000,000 ​ ​ 22,909,091 ​ Basic and diluted net income per share, Class A ​ $ - ​ $ 0.04 ​ $ 0.05 ​ $ 0.11 ​ Weighted average shares outstanding of Class B common stock ​ 5,750,000 ​ ​ 5,750,000 ​ 5,750,000 ​ ​ 5,750,000 ​ Basic and diluted net loss per share, Class B ​ $ (0.10) ​ $ (0.04) ​ $ (0.18) ​ $ (0.11) ​
Schedule of reconciliation of cash and cash equivalents	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2020 December 31, 2019 ​ Cash ​ $ 315,502 ​ $ 1,175,207 ​ Restricted cash equivalents held in Trust Account ​ 234,179,516 ​ 233,232,730 ​ Total cash and restricted cash equivalents held in Trust Account shown in the statement of cash flows ​ $ 234,495,018 ​ $ 234,407,937 ​

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Measurements
Schedule of assets that are measured on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, 2020 ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Active ​ Significant Other ​ Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets held in Trust: ​ ​ ​ ​ ​ U.S. Treasury Securities ​ $ — ​ $ — ​ $ — Cash equivalents - money market funds ​ 234,179,516 ​ — ​ — ​ ​ $ 234,179,516 ​ $ — ​ $ — ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ December 31, 2019 ​ Quoted Prices in ​ ​ ​ ​ ​ ​ ​ ​ Active ​ Significant Other ​ Significant Other ​ ​ Markets ​ Observable Inputs ​ Unobservable Inputs Description (Level 1) (Level 2) (Level 3) Assets held in Trust: ​ ​ ​ ​ ​ U.S. Treasury Securities ​ $ — ​ $ — ​ $ — Cash equivalents - money market funds ​ 233,232,730 ​ — ​ — ​ ​ $ 233,232,730 ​ $ — ​ $ — ​

Description of Organization and

Description of Organization and Business Operations (Details)	Feb. 19, 2019USD ($)$ / shares$ / itemshares	Feb. 12, 2019USD ($)$ / shares$ / itemshares	Nov. 06, 2018USD ($)$ / shares	Mar. 31, 2019USD ($)	Sep. 30, 2020USD ($)$ / shares$ / item	Dec. 31, 2019USD ($)$ / shares
Subsidiary, Sale of Stock [Line Items]
Deferred underwriting commissions					$ 8,050,000	$ 8,050,000
Warrants exercise price | $ / shares					$ 0.01
Capital contribution from Sponsor				$ 230,000,000	$ 230,000,000
Sale of units, price per unit | $ / item					10
Minimum percentage specified for aggregate fair market value of assets held in Trust Account					80.00%
Threshold percentage of outstanding voting securities in business combination					50.00%
Amount per share initially held in trust account | $ / shares					$ 10
Minimum amount of net tangible assets for business combination					$ 5,000,001
Redemption percentage of public shares					100.00%
Amount of interest released to pay dissolution expenses					$ 100,000
Operating Bank Account Held Outside Of The Trust Account					316,000
Investment Income, Interest					$ 4,200,000
Class A Common stock
Subsidiary, Sale of Stock [Line Items]
Capital contribution from Sponsor				$ 2,300
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001
Minimum threshold percentage of common stock sold in initial public offering					20.00%
Class B common stock
Subsidiary, Sale of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001
Sponsor
Subsidiary, Sale of Stock [Line Items]
Warrants exercise price | $ / shares					$ 1.50
Loans from Sponsor					$ 153,000
Sponsor | Class B common stock
Subsidiary, Sale of Stock [Line Items]
Capital contribution from Sponsor			$ 25,000		$ 25,000
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares		20,000,000
Units issue price per unit | $ / item		10
Over allotment option | Sponsor and Anchor Investors
Subsidiary, Sale of Stock [Line Items]
Number of warrant issued | shares	600,000
Warrants exercise price | $ / shares	$ 1.50
Proceeds from issuance of warrants	$ 900,000
Private Placement | Sponsor and Anchor Investors
Subsidiary, Sale of Stock [Line Items]
Number of warrant issued | shares		4,000,000
Warrants exercise price | $ / shares		$ 1.50
Proceeds from issuance of warrants		$ 6,000,000
Underwriting Agreement | Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Initial offering cost	13,400,000
Deferred underwriting commissions	$ 8,050,000
Underwriting Agreement | Over allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	3,000,000
Units issue price per unit | $ / item	10
Gross proceeds from units issued	$ 230,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Basic and diluted loss per common stock (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Summary Of Significant Accounting Policies [Line Items]
Interest income on restricted cash equivalents held in Trust Account	$ 28,551			$ 5,321			$ 1,153,171	$ 12,025
Gain on marketable securities (net), dividends and interest, held in Trust Account				1,142,497				3,299,930
Net (loss) income	(491,685)	$ (4,755)	$ 622,375	658,150	$ 852,775	$ 324,994	125,935	1,835,919
Class A Common stock
Summary Of Significant Accounting Policies [Line Items]
Expenses available to be paid with interest income from Trust	69,129			(282,380)			20,810	(818,514)
Net (loss) income	97,680			865,438			1,173,981	2,493,441
Less: Income attributable to Class A common stock	$ (97,680)			$ (865,438)			$ (1,173,981)	$ (2,493,441)
Weighted average shares outstanding	23,000,000			23,000,000			23,000,000	22,909,091
Basic and diluted net income per share				$ 0.04			$ 0.05	$ 0.11
Class B common stock
Summary Of Significant Accounting Policies [Line Items]
Net (loss) income	$ (589,365)			$ (207,288)			$ (1,048,046)	$ (657,522)
Weighted average shares outstanding	5,750,000			5,750,000			5,750,000	5,750,000
Basic and diluted net income per share	$ (0.10)			$ (0.04)			$ (0.18)	$ (0.11)

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Reconciliation of cash and cash equivalents (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Summary of Significant Accounting Policies
Cash	$ 315,502	$ 1,175,207
Restricted cash equivalents held in Trust Account	234,179,516	233,232,730
Total cash and restricted cash equivalents held in Trust Account shown in the statement of cash flows	$ 234,495,018	$ 234,407,937	$ 2,295,292	$ 37,044

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]
Federal Depository Insurance Coverage, amount	$ 250,000
Investments in marketable securities	0	$ 0
Cash equivalents held in Trust Account	234,200,000	233,200,000
Offering costs related to Initial Public Offering	13,400,000
Accrued offering costs		50,000
Unrecognized tax benefits	0	0
Unrecognized accrued interest and penalties	$ 0	$ 0
Class A Common stock
Summary Of Significant Accounting Policies [Line Items]
Number of shares issued for possible redemption	22,073,865	22,061,272
Number of common stock would be anti-dilutive under treasury stock method	12,266,666

Initial Public Offering (Detail

Initial Public Offering (Details) $ in Millions	Feb. 19, 2019USD ($)$ / itemshares	Feb. 12, 2019$ / itemshares
Subsidiary, Sale of Stock [Line Items]
Description of Initial Public Offering unit		Each Unit consists of one share of Class A common stock and one-third of one redeemable warrant (“Public Warrant”).
Class A Common stock | Public warrants
Subsidiary, Sale of Stock [Line Items]
Description for public warrant right	Each whole Public Warrant will entitle the holder to purchase one Class A common stock at an exercise price of $11.50 per share, subject to adjustment
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued		20,000,000
Units issue price per unit | $ / item		10
Initial Public Offering | Anchor Investors
Subsidiary, Sale of Stock [Line Items]
Number of units issued		2,530,000
Over allotment option | Underwriting Agreement
Subsidiary, Sale of Stock [Line Items]
Number of units issued	3,000,000
Units issue price per unit | $ / item	10
Additional gross proceeds | $	$ 30

Private Placement (Details)

Private Placement (Details) - USD ($)	Feb. 19, 2019	Feb. 12, 2019	Sep. 30, 2020
Subsidiary, Sale of Stock [Line Items]
Warrants exercise price			$ 0.01
Private Placement | Class A Common stock | Warrant
Subsidiary, Sale of Stock [Line Items]
Warrants exercise price	$ 11.50
Description of private placement warrant right	Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at $11.50 per share.
Private Placement | Sponsor and Anchor Investors
Subsidiary, Sale of Stock [Line Items]
Number of warrant issued		4,000,000
Warrants exercise price		$ 1.50
Proceeds from issuance of warrants		$ 6,000,000
Over allotment option | Sponsor and Anchor Investors
Subsidiary, Sale of Stock [Line Items]
Number of warrant issued	600,000
Warrants exercise price	$ 1.50
Proceeds from issuance of warrants	$ 900,000

Notes Payable (Details)

Notes Payable (Details) - USD ($)	Jun. 24, 2020	Sep. 30, 2020
Debt Instrument [Line Items]
Amount of Loan proceeds received		$ 41,666
Notes Payable | Paycheck Protection Program
Debt Instrument [Line Items]
Amount of Loan proceeds received	$ 41,666

Related Party Transactions (Det

Related Party Transactions (Details)	Dec. 17, 2018shares	Nov. 06, 2018USD ($)$ / sharesshares	Jan. 31, 2019USD ($)shares	Mar. 31, 2019USD ($)shares	Sep. 30, 2020USD ($)$ / sharesshares	Jun. 30, 2020shares	Mar. 31, 2020shares	Dec. 31, 2019$ / sharesshares	Sep. 30, 2019shares	Jun. 30, 2019shares	Dec. 31, 2018shares
Related Party Transaction [Line Items]
Issuance of Class B common stock to Sponsor | $				$ 230,000,000	$ 230,000,000
Warrants exercise price | $ / shares					$ 0.01
Class B common stock
Related Party Transaction [Line Items]
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001			$ 0.0001
Common stock shares outstanding				5,750,000	5,750,000	5,750,000	5,750,000	5,750,000	5,750,000	5,750,000	5,750,000
Number of forfeited shares				575,000
Class A Common stock
Related Party Transaction [Line Items]
Issuance of Class B common stock to Sponsor (in shares)				23,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001			$ 0.0001
Issuance of Class B common stock to Sponsor | $				$ 2,300
Common stock shares outstanding				1,119,837	926,135	876,966	876,491	938,728	968,745	1,034,560
Stock Conversion Ratio					1
Sponsor
Related Party Transaction [Line Items]
Reverse split ratio	0.8-for-1
Common stock shares outstanding	5,750,000
Due to related parties | $					$ 153,000
Working capital loans, amount | $					$ 1,500,000
Warrants exercise price | $ / shares					$ 1.50
Sponsor | Class B common stock
Related Party Transaction [Line Items]
Issuance of Class B common stock to Sponsor (in shares)		7,187,500
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Issuance of Class B common stock to Sponsor | $		$ 25,000			$ 25,000
Common stock shares outstanding	5,750,000
Number of forfeited shares			575,000
Sponsor | Class B common stock | Maximum
Related Party Transaction [Line Items]
Number of forfeited shares			750,000
Anchor Investors | Class B common stock
Related Party Transaction [Line Items]
Issuance of Class B common stock to Sponsor (in shares)			575,000
Issuance of Class B common stock to Sponsor | $			$ 2,300

Commitments & Contingencies (De

Commitments & Contingencies (Details)	Feb. 19, 2019USD ($)$ / shares$ / itemshares	Nov. 30, 2018USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)	Feb. 12, 2019$ / itemshares
Subsidiary, Sale of Stock [Line Items]
Payment made upon closing of Initial Public Offering						$ 4,758,272
Deferred underwriting commissions			$ 8,050,000		$ 8,050,000		$ 8,050,000
Monthly rent					8,000
Rent expense			38,000	$ 32,000	61,000	$ 61,000
Deferred legal fees			450,000		450,000		450,000
Prepaid Expenses and Other Current Assets [Member]
Subsidiary, Sale of Stock [Line Items]
Security Deposit			12,000		12,000		$ 32,000
Lease Agreement
Subsidiary, Sale of Stock [Line Items]
Monthly rent		$ 10,000
Security Deposit		$ 20,000	$ 12,000		$ 12,000
Over allotment option | Underwriting Agreement
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	3,000,000
Units issue price per unit | $ / item	10
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares								20,000,000
Units issue price per unit | $ / item								10
Initial Public Offering | Underwriting Agreement
Subsidiary, Sale of Stock [Line Items]
Underwriting discount per unit | $ / shares	$ 0.20
Payment made upon closing of Initial Public Offering	$ 4,600,000
Deferred underwriting commission per unit | $ / shares	$ 0.35
Deferred underwriting commissions	$ 8,050,000

Stockholder's Equity (Details)

Stockholder's Equity (Details)	Feb. 19, 2019shares	Dec. 17, 2018shares	Jan. 31, 2019shares	Mar. 31, 2019shares	Sep. 30, 2020$ / sharesshares	Dec. 31, 2019$ / sharesshares	Jun. 30, 2020shares	Mar. 31, 2020shares	Sep. 30, 2019shares	Jun. 30, 2019shares	Dec. 31, 2018shares	Nov. 06, 2018$ / shares
Stockholders Equity [Line Items]
Preferred stock, shares authorized					1,000,000	1,000,000
Preferred stock, shares issued					0	0
Preferred stock, shares outstanding					0	0
Warrants exercise price | $ / shares					$ 0.01
Number of days for written notice of redemption					30 days
Common stock equals or exceeds for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date | $ / shares					$ 18
Additionally minimum price of public warrants become exercisable prior written notice of redemption | $ / shares					10
Convertible exercisable or exchangeable for shares of common stock at an issue price | $ / shares					$ 9.20
Percentage of warrant exercise price in new issuance					115.00%
Sponsor
Stockholders Equity [Line Items]
Reverse split ratio		0.8-for-1
Common stock shares outstanding		5,750,000
Warrants exercise price | $ / shares					$ 1.50
Class A Common stock
Stockholders Equity [Line Items]
Common stock, shares authorized					100,000,000	100,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001
Common stock shares issued included possible redemption					23,000,000	23,000,000
Common stock shares outstanding included possible redemption					23,000,000	23,000,000
Number of shares issued for possible redemption					22,073,865	22,061,272
Common stock, shares issued					926,135	938,728
Common stock shares outstanding				1,119,837	926,135	938,728	876,966	876,491	968,745	1,034,560
Stock Conversion Ratio					1
Class B common stock
Stockholders Equity [Line Items]
Common stock, shares authorized					10,000,000	10,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001	$ 0.0001
Common stock, shares issued					5,750,000	5,750,000
Common stock shares outstanding				5,750,000	5,750,000	5,750,000	5,750,000	5,750,000	5,750,000	5,750,000	5,750,000
Number of forfeited shares				575,000
Percentage of issued and outstanding common stock after the initial public offering						20.00%
Voting rights of common stock					one vote
Class B common stock | Sponsor
Stockholders Equity [Line Items]
Common stock, par value (in dollars per share) | $ / shares												$ 0.0001
Common stock shares outstanding		5,750,000
Number of forfeited shares			575,000
Number of shares issued to underwriter	750,000
Class B common stock | Sponsor | Maximum
Stockholders Equity [Line Items]
Number of forfeited shares			750,000

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Quoted Prices in Active Markets (Level 1) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in Trust	$ 234,179,516	$ 233,232,730
Cash equivalents - money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in Trust	$ 234,179,516	$ 233,232,730

Fair Value Measurements - Trans

Fair Value Measurements - Transfer Between Levels (Details)	9 Months Ended
	Sep. 30, 2020USD ($)
Fair Value Measurements
Asset, Level 1 to Level 2 Transfer, Fair Value	$ 0
Asset, Level 2 to Level 1 Transfer, Fair Value	0
Asset, Level 3 Transfer, Fair Value	$ 0

Subsequent Events (Details)

Subsequent Events (Details) $ / shares in Units, $ in Millions	Oct. 05, 2020USD ($)director$ / sharesshares	Oct. 05, 2020USN ($)directorshares	Mar. 31, 2019shares	Sep. 30, 2019USD ($)
Subsequent Event [Line Items]
Proceeds from Issuance of Common Stock | $				$ 2,313
Class A Common stock
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues | shares			23,000,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Business Combination, Exchange Ratio Calculation, Numerator Divisor | $		$ 900
Stockholders' Agreement, Threshold Number OF Directors That Can Be Designated | director	2	2
Shares Issued, Price Per Share | $ / shares	$ 10
Subsequent Event [Member] | Class A Common stock | Private Placement
Subsequent Event [Line Items]
Subscription Agreements, Number Of Additional Shares With Option To Purchase | shares	2,500,000	2,500,000
Subsequent Event [Member] | Romeo Systems, Inc. [Member]
Subsequent Event [Line Items]
Merger Agreement, Lockup Period	180 days	180 days
Merger Agreement, Notice Period	45 days	45 days
Merger Agreement, Threshold Business Days Within Which Shareholders Approval Must Be Obtained	3 days	3 days
Subsequent Event [Member] | Sponsor
Subsequent Event [Line Items]
Stockholders' Agreement, Threshold Number OF Directors That Can Be Designated | director	2	2
Subsequent Event [Member] | Sponsor | Class A Common stock
Subsequent Event [Line Items]
Stock Issued During Period, Shares, New Issues | shares	15,000,000	15,000,000
Shares Issued, Price Per Share | $ / shares	$ 10
Proceeds from Issuance of Common Stock | $	$ 150,000,000
Subscription Agreement, Termination, Threshold Period At The Election Of Subscriber	270 days	270 days
Subsequent Event [Member] | Sponsor | Class A Common stock | Private Placement
Subsequent Event [Line Items]
Subscription Agreements, Period Of Option To Purchase Additional Shares	30 days	30 days
Subsequent Event [Member] | Sponsor | Class B common stock
Subsequent Event [Line Items]
Merger Agreement, Transfer Restriction Period From Closing Of Merger	1 year	1 year
Lock Up Agreement, Transfer Restrictions, Threshold Sale Price Per Share | $ / shares	$ 12
Lock Up Agreement, Trading Days	20 days	20 days
Lock Up Agreement, Trading Days After Closing Of Merger	150 days	150 days
Lock Up Agreement, Transfer Restriction Period	30 days	30 days
Subsequent Event [Member] | BorgWarner, Inc [Member]
Subsequent Event [Line Items]
Stockholders' Agreement, Threshold Number OF Directors That Can Be Designated | director	1	1